Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Gout Refractory to Conventional Therapy”

5 trials

Showing 5 of 5 results

Large-scale testing (Phase 3)Study completedNCT04596540
What this trial is testing

SEL-212 in Patients With Gout Refractory to Conventional Therapy II

Who this might be right for
Chronic Gout
Swedish Orphan Biovitrum 153
Not applicableStudy completedNCT01466166
What this trial is testing

Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout

Who this might be right for
Refractory Chronic Gout
Horizon Pharma Rheumatology LLC 188
Large-scale testing (Phase 3)Study completedNCT04513366
What this trial is testing

SEL-212 in Patients With Gout Refractory to Conventional Therapy

Who this might be right for
Chronic Gout
Swedish Orphan Biovitrum 112
Large-scale testing (Phase 3)Study completedNCT00675103
What this trial is testing

Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients

Who this might be right for
Chronic Gout Refractory to Conventional Therapy
Savient Pharmaceuticals 7
Testing effectiveness (Phase 2)Study completedNCT03905512
What this trial is testing

Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy

Who this might be right for
Chronic Gout
Selecta Biosciences, Inc. 170

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation